<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00728962</url>
  </required_header>
  <id_info>
    <org_study_id>2208</org_study_id>
    <nct_id>NCT00728962</nct_id>
  </id_info>
  <brief_title>A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading.</brief_title>
  <acronym>Fireball</acronym>
  <official_title>A Prospective, Observational Study of Osseotite Certain IOL (Immediate Occlusal Loading) Implants in Immediate Occlusal Loading of Short Span Fixed Restorations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, multicenter study evaluates the performance of the Osseotite Prevail
      implant when to support a short fixed bridge with immediate occlusal loading, providing the
      patient with the use of a temporary prosthesis until the final prosthesis is made.

      Study (null) hypothesis: This is an observational study in which no concurrent control group
      will be observed. Results of the study will be compared with the performance of other
      Osseotite implants from published Osseotite multicenter studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, observational study in which all the patients will have implants
      placed and a provisional prosthesis attached within 24 hours of implant surgery. Each
      restorative case will consist of a posterior short span fixed bridge of four implants or
      less. The final prosthesis will be placed within five months or implant placement surgery.
      Overall success will be determined on the basis of procedural success, prosthesis success,
      and implant success.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">May 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patients With Implants Achieving Osseous Integration</measure>
    <time_frame>1 year</time_frame>
    <description>Patients receiving test implant(s) will achieve integration success (implant show no signs of mobility) of the implant at the time of analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Crestal Bone Regression</measure>
    <time_frame>four years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">75</enrollment>
  <condition>Partial Edentulism</condition>
  <condition>Tooth Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        These will be patients who are otherwise seeking dental implant therapy and belong to the
        study centers' standard patient population.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of either sex and of any race, 18 years of age or older

          -  patients for whom the decision has already been made to use dental implants for
             treating partial edentulism in the posterior mandible or maxilla using a short span
             fixed prosthesis of two to four units

          -  patients must be physically able to tolerate conventional surgical and restorative
             procedures

          -  requirements for implant placement include: at least 1mm bone will be available at the
             buccal and lingual aspect of the implant and at least 1mm of bone below the apex

          -  patients must agree to return to the clinic for each study follow-up visit

          -  requirements for prosthetic fabrication include: bone width at least 6mm and a bone
             height of at least 11mm

        Exclusion Criteria:

          -  patients with active infection or severe inflammation in the areas intended for
             implant placement

          -  patients with a &gt;10 cigarettes / day smoking habit

          -  patients with uncontrolled diabetes or metabolic bone disease

          -  patients with a history of therapeutic radiation to the head

          -  patients in need of bone grafting at the site of the intended study implant; if at the
             time of surgery some lateral voids need to be filled this is acceptable and does not
             exclude the patient from the analysis

          -  patients who are known to be pregnant

          -  patients with para-functional habits with evidence of severe bruxing or clenching

          -  placement of implants into sites with less than sixteen weeks of post-extraction
             healing; for 3-4 unit cases one implant site may have less than sixteen weeks of
             healing prior to implant placement

          -  type III or IV bone characteristics of the intended implant sites

          -  inter-arch distance of less than 7mm (planned location of implant seating platform to
             the apposing occlusal landmark)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hessam Nowzari, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90089</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2008</study_first_submitted>
  <study_first_submitted_qc>August 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2008</study_first_posted>
  <results_first_submitted>June 26, 2009</results_first_submitted>
  <results_first_submitted_qc>January 18, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 5, 2010</results_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dental implants</keyword>
  <keyword>Osseotite Certain Prevail</keyword>
  <keyword>multicenter</keyword>
  <keyword>observational</keyword>
  <keyword>clinical study</keyword>
  <keyword>partial edentulism</keyword>
  <keyword>single stage</keyword>
  <keyword>immediate occlusal loading</keyword>
  <keyword>crestal bone level</keyword>
  <keyword>short fixed bridge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Salicylic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Each site endeavored to enroll a maximum of 15 patients, with enrollment efforts beginning in March 2005. Enrollment period remained open at all sites until April 2006. Three participating sites are Universities and four are private practices.</recruitment_details>
      <pre_assignment_details>Pre-treatment included a screening visit(enroll those meeting all study inclusion criteria), signing informed consent, and pre-surgical data collection. Within 48hrs., impressions of the patient's treatment areas are taken for making a temporary prosthesis. Patients are then scheduled for implant placement surgery.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Internal connection implant with an expanded platform and lateralization with a tapered apex</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Implant Placement Surgery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Permanent Prosthesis Placement</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>One Year Post Placement Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Two Year Post Placement Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Internal connection implant with an expanded platform and lateralization with a tapered apex</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Netherlands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patients With Implants Achieving Osseous Integration</title>
        <description>Patients receiving test implant(s) will achieve integration success (implant show no signs of mobility) of the implant at the time of analysis.</description>
        <time_frame>1 year</time_frame>
        <population>total number of patients enrolled in the study was used for primary outcome analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Osseotite Certain Prevail Implant</title>
            <description>Internal connection implant with an expanded platform and lateralization with a tapered apex</description>
          </group>
        </group_list>
        <measure>
          <title>Patients With Implants Achieving Osseous Integration</title>
          <description>Patients receiving test implant(s) will achieve integration success (implant show no signs of mobility) of the implant at the time of analysis.</description>
          <population>total number of patients enrolled in the study was used for primary outcome analysis</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Crestal Bone Regression</title>
        <time_frame>four years</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event reports are collected from day 1 to present; 4 years of study duration to date.</time_frame>
      <desc>Adverse event data is collected during each study event visit the patient is seen for.</desc>
      <group_list>
        <group group_id="E1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Internal connection implant with an expanded platform and lateralization with a tapered apex</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Loss of integration of implant</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Manager</name_or_title>
      <organization>Biomet 3i LLC</organization>
      <phone>5617766722</phone>
      <email>cristina.matthews@biomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

